|
Topic: Antigen recognition detains CD8+ T cells at the blood-brain barrier and contributes to its breakdown
Authors: Sidar Aydin and Javier Pareja Román (University of Bern – Bern, Switzerland) Presenter: Éloise Dufourd (INSERM, Université Toulouse III – Toulouse, France) Moderators: Maja Jagodic (Karolinska Institutet – Stockholm, Sweden) & Chiara Sorini (Karolinska Institutet – Stockholm, Sweden) Tuesday November 28, 2023 15:00 - 16:00 CET LINK:https://zoom.us/j/91227642247?pwd=ZitqNCt1YVNyRTJ5eU5SaXFVSkpwQT09 PASSCODE: ESNIJC |
|
10th Helani Congress
For more information on the 10th Helani Congress which will take place in Thessaloniki, Greece, from the 14th-17th of December, 2023, please click here.
|
|
Position paper on diagnosis and
|
first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease. Epidemiological data show that, cumulatively, optic neuritis is most frequently caused by many conditions other than multiple sclerosis. Worldwide, the cause and management of optic neuritis varies with geographical location, treatment availability, and ethnic background. We have developed diagnostic criteria for optic neuritis and a classification of optic neuritis subgroups. Our diagnostic criteria are based on clinical features that permit a diagnosis of possible optic neuritis; further paraclinical tests, utilising brain, orbital, and retinal imaging, together with antibody and other protein biomarker data, can lead to a diagnosis of definite optic neuritis. Paraclinical tests can also be applied retrospectively on stored samples and historical brain or retinal scans, which will be useful for future validation studies. Our criteria have the potential to reduce the risk of misdiagnosis, provide information on optic neuritis disease course that can guide future treatment trial design, and enable physicians to judge the likelihood of a need for long-term pharmacological management, which might differ according to optic neuritis subgroups.
For more information click here: https://doi.org/10.1016/S1474-4422(22)00200-9
For more information click here: https://doi.org/10.1016/S1474-4422(22)00200-9
HELLENIC ACADEMY OF NEUROIMMUNOLOGY
The Hellenic Academy of Neuroimmunology was founded in 2012 and aims to a) facilitate the communication and cooperation between clinicians,health scientists and of the biological sciences for the promotion and reinforcement of reserarch, education as well as the improvement of clinical results of immune-mediated diseases of the central and peripheral nervous system and muscles, b) support and promote basic and clinical research and education, as an institution of research and education in the field of neuroimmunology in Greece, c) actively participate in the coordination of initiatives regarding research and education in the field of neuroimmunology, both in Greece as well as in cooperation with the respective european and international institutions, d) organise medical conferences in the field of neuroimmunology and participate in any way in the joint organisation of conferences with domestic or foreign institutions, e) encourage new researchers in the field of neuroimmunology.
It constitutes the common effort of the following scientific institutions who are active in the field of Neuroimmunology in Greece: Aristotle University of Thessaloniki, University of Ioannina, Democritus University of Thrace, University of Thessaly, National and Kapodistrian University of Athens, University of Crete, University of Patras, Hellenic Pasteur Institute, Academy of Athens, Fleming Institute and the Centre for Research and Technology Hellas.
The Academy is a non profit and charitable company who aims at promoting research in the field of Neuroimmunology. Pursuant to its aim the Academy organises every year a Panhellenic Congress with the participation of important greek and international scientists. At the same time it participates in international conferences, it grants aegis to national scientific events and reinforces through awards and research grants, research efforts carried out by research institutions in Greece.
It constitutes the common effort of the following scientific institutions who are active in the field of Neuroimmunology in Greece: Aristotle University of Thessaloniki, University of Ioannina, Democritus University of Thrace, University of Thessaly, National and Kapodistrian University of Athens, University of Crete, University of Patras, Hellenic Pasteur Institute, Academy of Athens, Fleming Institute and the Centre for Research and Technology Hellas.
The Academy is a non profit and charitable company who aims at promoting research in the field of Neuroimmunology. Pursuant to its aim the Academy organises every year a Panhellenic Congress with the participation of important greek and international scientists. At the same time it participates in international conferences, it grants aegis to national scientific events and reinforces through awards and research grants, research efforts carried out by research institutions in Greece.
